Mayim Bialik thought a buzzy weight-loss drug might finally quiet years of autoimmune misery—instead, she writes in the Free Press, it triggered a weeklong ordeal she compares to an allergic reaction. In a first-person essay, the actor and former Jeopardy! host traces how early menopause and multiple autoimmune diagnoses led three doctors to recommend a GLP-1 drug not for vanity, but in hopes of easing inflammation. One low-dose shot, she says, brought on days of violent gastrointestinal symptoms so severe she needed IV fluids at home—yet her medical team, she notes, seemed largely unfazed.
"My experience, it turns out, is far from rare," Bialik writes, citing clinical trials showing high rates of nausea, vomiting, and diarrhea and thousands of US lawsuits alleging gastrointestinal injury, vision loss, or wrongful death. A gastroenterologist ultimately told her these drugs are "extremely disruptive" and should be reserved for serious obesity. Still, she admits, even at her sickest she caught herself thinking that weight loss might be worth the "explosive, uncontrollable diarrhea" and "full-body aching." For her full account—and her questions about how far we'll go to chase thinness—read the original piece at the Free Press.